Webinar on lipids and oncology, presented by Dr. Catherine Field and Dr. Robert Chapkin, two of the world’s leading experts in the molecular mechanisms by which lipids modulate cancer risk and therapy. Together with DSM’s Dr. Keri Marshall, they will discuss the evidence for the use of lipids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as a part of neoadjuvant therapy for two of the most common cancers: breast and colon. Click Here for Webinar.
Researchers developing signal processing techniques to identify gut microbial biomarkers of colon cancer
An interdisciplinary team of researchers at Texas A&M University has been awarded a Division of Computing and Communication Foundations grant by the National Science Foundation to develop a gut-microbial investigation model that can identify critical dietary risk factors that cause colorectal cancer. The three-year, $350,000 project is a direct outcome of Texas A&M Engineering Experiment Station’s Interdisciplinary Seed Grants for Strategic Initiatives, which provided initial funding to establish the collaborative research effort. Continue Reading…
Huffines Institute Podcast- Dr. Robert Chapkin and Dietary Chemo-Prevention
The Huffines Institute at Texas A&M University hosted Dr. Chapkin on their Friday Podcast. Dr. Chapkin discussed his work with Dietary Chemo-prevention, Dietary methods, and Chronic Disease. If you are looking at how beneficial nutrition can be to cancer prevention this conversation is for you! LISTEN NOW
*Transcript will be available here.
Robert Fuentes Becomes Finalist
Robert Fuentes becomes finalist in the 3 Minute Thesis Competition.
Robert presented his thesis work in 3 minutes and was selected as a finalist for the competition on November 16. The winner will represent Texas A&M at the Conference of Southern Graduate Schools regional competition in Fayetteville, AK in February. Good luck to Robert!
Robert Fuentes Successfully Defended His Thesis, Won 1st Place at Toxicology Meeting
On Monday, September 11, 2017. N. Roberto Fuentes, Jr. successfully defended his thesis titled, “Plasma Membrane Lipid Therapy: Distruption of Oncogenic Ras Driven Phenotypes by Long Chain N-3 PUFA.”
Then on October 13, 2017, Robert placed first in the graduate student presentation competition at the Lone Star Society of Toxicology Regional Meeting at Baylor University.
The title of his talk was “Plasma membrane lipid therapy: Disruption of oncogenic Ras spatiotemporal organization by membrane targeted dietary bioactives (MTDB)”.
Robert is a Toxicology Doctoral Candidate at Texas A&M University and works in the Chapkin Lab.